Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 22,768 shares at an average $65.91 ($1,500,589)
  2. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $67.79 ($16,948)
  3. 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 2,799 shares (to pay taxes)
  4. 4 Shares withheld for taxes SVP & CFO gave up 4,534 shares (to pay taxes)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Planned sale SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $67.25 ($1,345,000)
  7. 4 Shares withheld for taxes SVP & CFO gave up 6,210 shares (to pay taxes)
  8. 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 3,653 shares (to pay taxes)
  9. 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,455 shares (to pay taxes)
  10. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $66.54 ($16,635)
  11. 4 Planned sale SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $65.81 ($1,316,200)
  12. 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 10,000 shares at $67.17 ($671,700)
  13. 4 Open-market sale SVP & CFO sold 7,787 shares at $65.55 ($510,438)
  14. 4 Open-market sale PRESIDENT & CEO sold 45,257 shares at an average $66.10 ($2,991,469)
  15. 4 Open-market sale SVP OPS & PROD DEV sold 24,338 shares at $66.37 ($1,615,313)
  16. 4 Shares withheld for taxes SVP, GENERICS gave up 2,494 shares (to pay taxes)
  17. 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 2,110 shares (to pay taxes)
  18. 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 40,000 shares at an average $65.77 ($2,630,864)
  19. 4 Open-market sale HEAD OF RARE DISEASE sold 5,000 shares at $66.00 ($330,000)
  20. 4 Open-market sale Director sold 7,000 shares at $65.20 ($456,400)

Page 10 of 42 · 835 filings